 |
Selective inhibitor of polymorphonuclear leukocyte (PMN) elastase |
|---|---|
| Trade Name | |
| Orphan Indication | Therapeutic management of patients with lung disease attributable to cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1996-06-04 00:00:00 |
| Sponsor | DuPont Pharmaceuticals Company;Chestnut Run, Maple Run, Centre Rd.;Wilmington, Delaware, 19805 |
